Journal of Sasang Constitutional Medicine (사상체질의학회지)

The Society Of Sasang Constitutional Medicine (사상체질의학회)
권호 표지
DOI QR코드

DOI QR Code

Attitude and awareness of Sasang Constitution Investigators on the Informed Consent

체질의학 임상연구자의 피험자 동의서 취득에 대한 인식도 조사

  • Received : 2011.07.29
  • Accepted : 2011.09.05
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

1. Objectives: We surveyed the attitude and awareness of Sasang Constitution investigators on informed consent in clinical study. This study was performed in order to improve the quality of ethical aspects in clinical study by surveying the process of obtaining informed consent. 2. Methods: We sent the questionnaire by email to Sasang Constitution investigators who had the experience in clinical study. The question was about the necessity of informed consent and the process of obtaining it. 3. Results: Twenty-two out of 24 questionnaires were collected. All of investigators recognized that informed consent is needed for clinical study. Sixty-four percent of the respondents 'fully' or 'mostly' explained the informed consent but they added only 41% of participants 'fully' or 'mostly' understood. Fifty-four point five percent of respondents provided participants enough time and opportunity to inquire the study in details to decide whether or not to participate in the study, the rest of respondents obtained informed consent without providing enough time for decision. 4. Conclusions: Sasang Constitution investigators had high awareness of necessity for informed consent in clinical study. But participants' understanding was low despite of the degree of investigators' explanation. A various strategies should be designed for improving consent forms and process. Most of all, investigators should make sure that informed consent intends to protect participants and promote ethical research conduct.

Keywords

References

  1. Sakett DL, Straus SE, Richardson WS, Rosenberg WR, Hayness RB. Evidence-based medicine London. Haricourt. 2. Buetow S, Kenealy T. Evidence-based medicine the need for a new definition. J Eval Clin Pract. 2000;6:85-92. https://doi.org/10.1046/j.1365-2753.2000.00237.x
  2. Buetow S, Kenealy T. Evidence-based medicine the need for a new definition. J Eval Clin Pract. 2000;6:85-92. https://doi.org/10.1046/j.1365-2753.2000.00237.x
  3. 식품의약품안전청. 임상시험정책방향. 2011. Avaiable from: URL:http://clinicaltrials.kfda.go.kr/info/morgue/ board_list.jsp
  4. The Nuremberg Code. Nuremberg Military Tribunal. 1947.
  5. World Medical Association Declaration of Helsinki :Ethical Principles for Medical Research Involving Human Subjects. 2000. Available from: URL:http:// www.wma.net/e/policy/b3.htm
  6. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. The National Commission for the Protection of Human Subjects of Biomedical and Behaviral Research April 18, 1979. Avaiable from: URL:http://www.hhs.gov/ ohrp/humansubjects/guidance/belmont.htmURL:http://www.hhs.gov/ ohrp/humansubjects/guidance/belmont.htm
  7. ICH-GCP. Guidelines for Goodl Clinical Practice for Trials on Pharmaceutical Products. World Health Organization. 1995.
  8. Emanuel E, Wendler D, Grady C. What makes Clinical Research Ethical? JAMA. 2000;283(20):2701-11. https://doi.org/10.1001/jama.283.20.2701
  9. Kim OJ, Choi EK. Bioethics and Protection of Personal Information in Observational Studies. Korea Jounal of Epidemiology. 2006;28(2):129-137. (Korean)
  10. Kim OJ. Bioethics and Protection of Personal Information in Experimental Studies. Korea Jounal of Epidemiology. 2007;29(1):1-12. (Korean)
  11. 약사법 시행규칙 별표 3의 2. 의약품 임상시험 관리기준(제32조 관련). 2011.5.6.
  12. Shim MJ, Lim YC. Novel Classification of the Informed Consent Process in Clinical Research and the Ways to Improve Each Detailed Stage. Kor J Clin Pharmacol Ther. 2009;17(1):5-26. (Korean) https://doi.org/10.1038/mt.2008.278
  13. Kim SW, Kang BK, Park GM, Hahn SJ, Kim EJ, Kim DY. Comprehension and conduct of physicians when acquiring informed consent for chemotherapy. Korean J Intern Med. 2010;78(5):610-615. (Korean)
  14. Lee SH, Choi BI, Kim CM, Kim KS. A Survey on Perception of Clinical Trial of Pharmaceuticals and Informed Consent in Korea. Kor J Clin Pharmacol Ther 2009;17(1):72-92. (Korean)
  15. Moon HL, Kim HK, Lee KS, Kang BK, Song HH. A survey of the Cognition on Clinical Trial and Informed Consent of Cancer patients and Their families. Pharmacol Ther. 1995;3(2):141-150. (Korean)
  16. Shin HY, The suggestions for improving informed consent in clinical trials. Kor J Clin Pharmacol Ther 2008; 16(1):13-20. (Korean)
  17. Jeong IS, Shon JH, Shin JG. Evaluating the Quality of Informed Consent in Clinical Research. Korean J Med Ethics. 2010;13(1):43-58. (Korean)
  18. Lee SW, Hwang JH, Yu JH, Oh SY, Joo JC, Jang ES, A Survey of on the Sasang Constitution Clinical Study-In the Journal of Sasang Constitution Medicine. J of Sasang Constitutional Medicine. 2008;20(2):21-29. (Korean)
  19. Michael K, Paasche-Orlow, Holly A, Branacati, Frederick L. Readability standards for informed consent forms as compared with actual readability. New England Journal of Medicine. 2003;348(8):721-726. https://doi.org/10.1056/NEJMsa021212
  20. Mosely TH, Wiggins MN, O'Sullivan P. Effect of presentation method on the understanding of informed consent. Br J Ophthalmol. 2006;90:990-993. https://doi.org/10.1136/bjo.2006.092650
  21. Institutional Review Board: management and function. Robert Mudur, Elizabeth Bankert. Canada. 2002:282- 286.
  22. Jefford M, Moore R. 2008. Improvement of informed consent and the quality of consent documents. Lancet oncology. 2008;9:485-93. https://doi.org/10.1016/S1470-2045(08)70128-1
  23. Maeng KH. Informed consent in public health activities: based on the universal declaration on bioethics and human rights, UNESCO. I Prev Med Public Health. 2008;41:339-344. (Korean) https://doi.org/10.3961/jpmph.2008.41.5.339
  24. 이덕환. 의료행위와 법. 서울: 문영사. 1998:25-32.